RE:RE:Earnings: Nov 30At the webinar last week he said they had $3.8 million in cash on hand. Some of that is no doubt because of warrants being redeemed, but my expectation is similar numbers to Q2 in terms of revenue and profitability (EBITDA positive or close to it). Even if there are more expenses against the revenues, I shouldn't tank the stock as everybody paying attention realizes where the money has been going. I'm not worried.
cactuseskimo wrote: Hmmm, good thing or bad thing for the SP? I can't imagine their bottom line looks that great with all the money spent bringing the BioCloud to market.